AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
BioXcel Therapeutics announced that CEO Vimal Mehta will participate in a fireside chat at the Canaccord Genuity 45th Annual Growth Conference on Aug. 12, 2025, at 12 p.m. ET. The webcast will be available on the company's website for 90 days. BioXcel Therapeutics is a biopharmaceutical company using AI to develop transformative medicines in neuroscience.
BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company leveraging artificial intelligence (AI) to develop transformative medicines in neuroscience, has announced that its CEO, Vimal Mehta, Ph.D., will participate in a fireside chat at the Canaccord Genuity 45th Annual Growth Conference on Tuesday, August 12, 2025, at 12 p.m. ET. The event will take place in Boston, and investors can access the webcast through the company's website under the "Events & Presentations" page. The replay will be available for 90 days [1].Daily stocks & crypto headlines, free to your inbox
Comments
No comments yet